Business

Cipher Pharmaceuticals Schedules Q1 2023 Earnings Release and Conference Call

Cipher Pharmaceuticals Schedules Q1 2023 Earnings Release and Conference Call Canada Ne...

articleCipher Pharmaceuticals Inc.May 4, 20233/company/cipher-pharmaceuticals-inc/news/cipher-pharmaceuticals-schedules-q1-2023-earnings-release-and-conference-call
Cipher Pharmaceuticals Schedules Q1 2023 Earnings Release and Conference Call

About this update from Cipher Pharmaceuticals Inc.

[{"type":"text","content":"\n \n \n \n Cipher Pharmaceuticals Schedules Q1 2023 Earnings Release and Conference Call\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n \n MISSISSAUGA, ON\n \n \n ,\n \n \n May 4, 2023\n \n \n /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (\"\n \n Cipher\n \n \" or \"the\n \n Company\n \n \") today announced that it will release its financial results for the first quarter of 2023 on\n \n Thursday, May 11, 2023\n \n . The Company will also host a conference call on\n \n Friday, May 12, 2023\n \n at\n \n 8:30am ET\n \n to discuss the results and corporate developments.\n \n \n \n CONFERENCE CALL DETAILS\n \n \n \n DATE:\n \n Friday, May 12, 2023\n \n \n TIME:                                     8:30 a.m. EDT\n \n DIAL-IN NUMBER:                (416) 764-8650 or (888) 664-6383\n \n CONFERENCE ID:                40452017\n \n REPLAY DIAL-IN:                  (888) 390-0541 (playback 452017#)\n \n Expires\n \n May 19, 2022\n \n \n WEBCAST:\n \n https://app.webinar.net/wOPDyeLaKb0\n \n \n \n \n About Cipher Pharmaceuticals Inc.\n \n \n Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in\n \n Canada\n \n or indirectly through partners in\n \n Canada\n \n , the U.S., and\n \n South America\n \n . For more information, visit\n \n www.cipherpharma.com\n \n .\n \n \n SOURCE Cipher Pharmaceuticals Inc.\n \n \n \n \n \n \n View original content:\n \n http://www.newswire.ca/en/releases/archive/May2023/04/c9102.html\n \n \...

More updates from Cipher Pharmaceuticals Inc.